how does glp 1 work for weight loss glp-1_analogs [TUSOM GLP-1 and Anesthesia: Considerations and

A Mediterranean diet was found to result in higher GLP-1 release than a Western diet (Huber et al 2024)

Safety monitoring for GLP-1 therapy itself includes: Assessment for gastrointestinal adverse effects, which are common but usually transient Monitoring for signs of pancreatitis (severe, persistent abdominal pain) Vigilance for symptoms suggesting thyroid masses (neck lump, difficulty swallowing, persistent hoarseness) Regular review of glycaemic control in diabetic patients Blood pressure and cardiovascular risk factor assessment Monitoring for gallbladder disease (right upper abdominal pain, fever, jaundice) Eye examinations for people with diabetes, particularly those with pre-existing diabetic retinopathy Renal function checks, especially if experiencing severe gastrointestinal symptoms that could lead to dehydration If you have diabetes and take insulin or sulfonylureas, your doctor may reduce these doses when starting GLP-1 therapy to prevent hypoglycaemia

Its substrates also include pituitary adenylate cyclaseactivating polypeptides, insulinlike growth factor1, peptide YY, substance P, neuropeptide Y, gastrinreleasing polypeptides, and several chemokines, indicating its role in additional homeostatic functions, such as neurogenic inflammation, blood pressure control, and immune regulation [41]

IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

-Driver: Rising global demand for affordable alternatives to expensive biologic therapies

However, patients with symptomatic gallstones should typically undergo surgical evaluation and possible gallbladder removal before starting these medications to prevent complications during treatment